Archives by Month:

Archives by Year:

Mutual/Hedge Fund Favorites Tank In Q1

Mutual/Hedge Fund Favorites Tank In Q1

Mutual and hedge fund favorites have taken a beating in the first quarter so far, dragging down most funds right along with them. Long-only and levered hedge funds were among the hardest-hit as the stock market favored stocks with low institutional ownership. At least one firm has highlighted that individual investors who have bet agaibet aga institutions […]
Recipe For Collapse: Rising Military And Social Welfare Spending

Recipe For Collapse: Rising Military And Social Welfare Spending

Leaders faced with unrest, rising demands and dwindling coffers always debauch their currency as the politically expedient “solution.” Whatever you think of former Fed chair Alan Greenspan, he is one of the few public voices identifying runaway entitlement costs as a structural threat to the economy and nation. We can summarize Greenspan’s comments very succinctly: there is […]
Fly Away From Helicopter Money

Fly Away From Helicopter Money

Photo Credit: Shiny Things || Apologies, this was the best I could find at Flickr with a Creative Commons License Once I wrote a piece advocating helicopter money, and I called it 2300 Smackers. For those who were not reading me back during the bailout, you should know that I vociferously opposed it, and wrote a lot […]
Gold Marks First Gain In Four Sessions

Gold Marks First Gain In Four Sessions

Gold prices edged slightly higher on Tuesday, putting an end to three-session streak of declines, as investors sought safety after several explosions rocked Brussels. The XAU/USD pair traded as high as $1260.12 an ounce but investors’ risk aversion faded over the course of the day and as a result the market pared gains – similar […]
E
                                                
                        Twitter’s Latest Announcement Another Nail In The Coffin

E Twitter’s Latest Announcement Another Nail In The Coffin

In January, investors got a nice surprise when a report surfaced that the social media platform planned to increase its flagship 140-character limit to 10,000 characters. The limit, while central to Twitter’s product, is restrictive to the network’s ability to grow its user base. Some people simply don’t have the patience to try to condense […]
The Longer This Happens, The Better Your Investments Will Perform

The Longer This Happens, The Better Your Investments Will Perform

Morgan Stanley recently issued an alert saying that going long on the S&P 500 Index presented the best buying opportunity in 20 years. To investors still caught up in the sky-is-falling talk that’s been spewing out of the talking heads on cable, that might sound absurd. But not to you. That’s because I’ve been keeping you on top […]
Is It Time For Silver To Shine?

Is It Time For Silver To Shine?

The precious metals are likely to see another week closing out with prices settling higher in the longer term. On a week to date basis, Gold prices have lost -1.83% while Silver is down -1.45%. Yesterday’s terror attacks in Brussels saw investors bid up the safe-haven Gold sending prices back above the $1250 handle and it is […]
Why A Global Diversified Portfolio?

Why A Global Diversified Portfolio?

This article has been removed at the author’s request. The original post can be found here: https://investment-fiduciary.com/2016/03/22/why-a-global-diversified-portfolio/
Bank Of Japan Unleashes Yield Curve Chaos: JGBs Inverted At Short- And Long-End

Bank Of Japan Unleashes Yield Curve Chaos: JGBs Inverted At Short- And Long-End

You know you have ‘tinkered’ too much in the machinations of what dealers now call a “dead market” when the world’s largest sovereign bond market is inverted at the short-end and the long-end.The utter folly of Peter Pan policy has sent 10Y JGB yields below the BoJ’s overnight call rate for the first time ever… Japan’s […]
Corvus Announces Pricing Of Initial Public Offering

Corvus Announces Pricing Of Initial Public Offering

BURLINGAME, Calif., March 22, 2016 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology therapies, today announced the pricing of its initial public offering of 4,700,000 shares of its common stock at an initial public offering price of $15.00 per share. In addition, […]